Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections in hospitalized patients, including pneumonia, intra‑abdominal infections, and sepsis.

GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious infections caused by Gram‑negative and Gram‑positive bacteria. It is indicated for: - Complicated intra‑abdominal infections: eradicates mixed aerobic and anaerobic pathogens. - Hospital‑acquired pneumonia, including ventilator‑associated pneumonia: provides rapid bacterial clearance. - Complicated urinary tract infections: treats resistant Enterobacteriaceae. - Bacterial meningitis: penetrates the cerebrospinal fluid to eliminate causative organisms. - Sepsis and febrile neutropenia: offers empiric coverage against multidrug‑resistant organisms.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruptions. - Headache: transient and usually resolves. - Phlebitis at infusion site: redness and tenderness. - Elevated liver enzymes: transient transaminase rise.

Serious or Rare Side Effects: - Seizures: especially in patients with renal dysfunction. - Anaphylaxis: acute hypersensitivity reaction. - Clostridioides difficile‑associated diarrhea: severe colitis. - Renal impairment: acute kidney injury. - Severe neutropenia: marked reduction in neutrophil count. - Thrombocytopenia: low platelet levels leading to bleeding risk.

Before initiating therapy, consider the following precautions: - Renal function: adjust dose in patients with impaired clearance. - Allergy: avoid if hypersensitivity to carbapenems or β‑lactams exists. - Pregnancy: use only when benefits outweigh potential risks. - Concomitant valproic acid: monitor for reduced anticonvulsant levels. - Drug‑resistant organisms: obtain susceptibility data before use. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with several agents that alter its efficacy or safety. Major Interactions (Avoid): - Valproic acid: reduces plasma concentrations, risking seizure breakthrough. - Probenecid: may increase meropenem levels, heightening toxicity. Moderate Interactions (Monitor Closely): - Loop diuretics: monitor electrolytes for additive nephrotoxicity. - Aminoglycosides: watch for combined renal impairment. - Anticoagulants (warfarin): check INR for possible potentiation. - Other antibiotics: assess for antagonistic effects when combined with bacteriostatic agents.